MuriGen Therapeutics
Latest round
- Series A
Last raised
- Dec 2006
Total raised
- $3.9M
Investors
- 1
About MuriGen Therapeutics
Based in Melbourne, Australia, MuriGen Therapeutics is a pharmaceutical company. It engaged in the discovery, development, and commercialization of novel drugs across a number of therapeutic areas including cancer, arthritis, thrombocytopenia, inflammatory diseases, epilepsy, and thalassemia.
Who invested in MuriGen Therapeutics
1 investor across 1 round
See all investors in MuriGen Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 20, 2006
Amount
$3.9M
Investors
Questions about MuriGen Therapeutics
Who invested in MuriGen Therapeutics?
MuriGen Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MuriGen Therapeutics raised?
MuriGen Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MuriGen Therapeutics last raise money?
MuriGen Therapeutics's most recent round on record is a Series A, in Dec 2006.
What does MuriGen Therapeutics do?
Based in Melbourne, Australia, MuriGen Therapeutics is a pharmaceutical company.
Where is MuriGen Therapeutics headquartered?
MuriGen Therapeutics is headquartered in Melbourne, Australia.
Which VCs invest in companies like MuriGen Therapeutics?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back pharmaceuticals companies at MuriGen Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like MuriGen Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.